{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:16:04Z","timestamp":1794971764549,"version":"4.9.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00296-021-04887-3","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T10:02:52Z","timestamp":1621418572000},"page":"1833-1837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-8639","authenticated-orcid":false,"given":"Nikolaos","family":"Kougkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bertsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Papalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argiro","family":"Repa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prodromos","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Avgoustidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"issue":"suppl 1","key":"4887_CR1","first-page":"46","volume":"1","author":"LE Shulman","year":"1974","unstructured":"Shulman LE (1974) Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol 1(suppl 1):46\u201349","journal-title":"J Rheumatol"},{"key":"4887_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2214\/ajr.184.1.01840169","volume":"184","author":"F Baumann","year":"2005","unstructured":"Baumann F, Br\u00fchlmann P, Andreisek G, Michel BA, Marincek B, Weishaupt D (2005) MRI for diagnosis and monitoring of patients with eosinophilic fasciitis. AJR Am J Roentgenol 184:169\u2013174. https:\/\/doi.org\/10.2214\/ajr.184.1.01840169","journal-title":"AJR Am J Roentgenol"},{"key":"4887_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","volume":"17","author":"S Lakhanpal","year":"1988","unstructured":"Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17:221\u201331","journal-title":"Semin Arthritis Rheum"},{"key":"4887_CR4","first-page":"65","volume":"24","author":"M Scheinberg","year":"2006","unstructured":"Scheinberg M, Hamerschlak N, Kutner JM, Ribeiro AA, Ferreira E, Goldenberg J, Kiss MH, Cjahade WH (2006) Rituximab in refractory autoimmune diseases: Brazlian experience with 29 patients. Clin Exp Rheumatol 24:65\u20139","journal-title":"Clin Exp Rheumatol"},{"key":"4887_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/md.0b013e3182899e78","volume":"92","author":"A De Masson","year":"2013","unstructured":"De Masson A, Bouaziz JD, Peffault de Latour R, Benhamou Y, Molu\u00e7on-Chabrot C, Bay JO, Laquerri\u00e8re A, Picquenot JM, Michonneau D, Leguy-Seguin V, et al (2013) Severe aplastic anemia associated with eosinophilic fasciitis. Medicine 92:69\u201381. https:\/\/doi.org\/10.1097\/md.0b013e3182899e78","journal-title":"Medicine"},{"key":"4887_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23937\/2469-5726\/1510021","volume":"1","author":"G Thomson","year":"2015","unstructured":"Thomson G, Johnston JL, Thomson BRJ (2015) Eosinophilic fasciitis treated with tocilizumab: demonstration of efficacy after withdrawal and re-challenge in a patient. J Rheum Dis Treat 1:1\u20133","journal-title":"J Rheum Dis Treat"},{"issue":"2","key":"4887_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jdcr.2017.09.006","volume":"4","author":"WH Chan","year":"2018","unstructured":"Chan WH, Lewis DJ, Kim EJ, Aung PP, Duvic M (2018) Generalized morphea\/eosinophilic fasciitis overlap after epoxy exposure. JAAD Case Rep 4(2):175\u2013178. https:\/\/doi.org\/10.1016\/j.jdcr.2017.09.006","journal-title":"JAAD Case Rep"},{"issue":"5","key":"4887_CR8","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ijd.13940","volume":"57","author":"AF Nahhas","year":"2018","unstructured":"Nahhas AF, Alam M, Lim HW (2018) Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis. Int J Dermatol 57(5):614\u2013615. https:\/\/doi.org\/10.1111\/ijd.13940","journal-title":"Int J Dermatol"},{"issue":"3","key":"4887_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/rheumatology\/ker366","volume":"51","author":"D Lebeaux","year":"2012","unstructured":"Lebeaux D, Franc\u00e8s C, Barete S, Wechsler B, Dubourg O, Renoux J, Maisonobe T, Benveniste O, Gatfoss\u00e9 M, Bourgeois P et al (2012) Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatol (Oxf) 51(3):557\u2013561. https:\/\/doi.org\/10.1093\/rheumatology\/ker366","journal-title":"Rheumatol (Oxf)"},{"key":"4887_CR10","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2796.2009.02207.x","volume":"267","author":"F Perosa","year":"2010","unstructured":"Perosa F, Prete M, Racanelli V, Dammacco Fl (2010) CD20-depleting therapy in autoimmune diseases: from basic research to the clinic. J Intern Med 267:260\u201377. https:\/\/doi.org\/10.1111\/j.1365-2796.2009.02207.x","journal-title":"J Intern Med"},{"key":"4887_CR11","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","volume":"74","author":"S Jordan","year":"2015","unstructured":"Jordan S, Distler JH, Maurer B, Huscher D, van Laar JM, Allanore Y on behalf of the EUSTAR Rituximab study group (2015) Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheumat Dis 74:1188\u20131194. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204522","journal-title":"Ann Rheumat Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04887-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04887-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04887-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:28:52Z","timestamp":1630024132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04887-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4887"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04887-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent for the publication of this report was obtained from all patients by the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}